De Vera, Dante E.
HRN: 27-22-96 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2026
CLINDAMYCIN 300MG (CAP)
07/17/2026
07/23/2026
PO
300mg
TID
Cellulitis
Checking Final Appropriateness
Indication: EmpiricEmpirical Escalation Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes